How to set up a psychedelic study: Unique considerations for research involving human participants
arXiv Preprint Archive – March 28, 2025
Source: arXiv
Summary
Establishing psychedelic research trials is uniquely complex, challenging existing medical assumptions. Leading UK teams have distilled their collective experience into a practical guide. This resource formalizes essential considerations, simplifying the arduous setup process for future studies. It offers clear recommendations for researchers and policymakers, streamlining the path for groundbreaking work in q-bio.NC and advancing our understanding of these powerful compounds.
Abstract
Setting up a psychedelic study can be a long, arduous, and kafkaesque process. This rapidly-developing field poses several unique challenges for researchers, necessitating a range of considerations that have not yet been standardised. Many of the complexities inherent to psychedelic research also challenge existing assumptions around, for example, approaches to psychiatric prescribing, the conceptual framing of the placebo effect, and definitions of selfhood. This review paper brings together several of the major psychedelic research teams across the United Kingdom to formalise these unique considerations, identify continuing areas of debate, and provide a practical, experience-based guide, with recommendations for policymakers and future researchers intending to set up a psychedelic research study or clinical trial. We approach this such that the paper can either be read end to end, or treated as a manual: readers can dip into relevant sections as needed.